Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786655 | PMC |
| http://dx.doi.org/10.1038/s41429-021-00460-z | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Surgical treatment of Gorham-Stout disease combined with scoliosis: a case report and literature review.
BMC Musculoskelet Disord
December 2024
Department of Orthopaedic Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Science, Beijing, People's Republic of China.
Background: Gorham-Stout disease (GSD) is a rare disease characterized by osteolysis and lymphatic malformations. GSD involving the spine is exceptionally rare and lacks a standard cure. The aim of this article was to report a case of GSD with scoliosis treated via corrective surgery and medication.
View Article and Find Full Text PDFCorrection: Review of the novel antifungal drug olorofim (F901318).
BMC Infect Dis
December 2024
Department of Haematology, Department of Microbiology, Immunology and Transplantation, University Hospitals Leuven, KU Leuven, Herestraat 49, Leuven, 3000, Belgium.
Candidemia Surveillance and Impact on Non-neutropenic Critically Ill Patients.
Cureus
November 2024
The Michael and Marian Ilitch Department of Surgery, Wayne State University School of Medicine, Detroit, USA.
Article Synopsis
- Candidemia is a major concern in critically ill patients, significantly affecting their morbidity and mortality, and is linked to various risk factors.
- A retrospective study of 91 non-neutropenic critically ill adults examined the relationship between antifungal therapy effectiveness and patient outcomes, finding that improper or delayed treatment increased mortality rates.
- Key risk factors for higher mortality included mechanical ventilation, vasopressor therapy, end-stage renal disease, and multiple organ failures; patients receiving inadequate antifungal therapy had a much higher mortality rate (64%) compared to those receiving appropriate treatment (29%).
Case report: Unveiling the silent threat in the ICU - a case of disseminated invasive aspergillosis in a patient with fulminant myocarditis.
Front Immunol
December 2024
Fourth Department of Critical Care Medicine, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, Fujian, China.
Invasive aspergillosis (IA) significantly increases mortality in critically ill patients in the ICU and its occurrence is closely related to immunocompromise. Dissemination of IA is easily misdiagnosed and mistreated due to its ability to invade multiple systems throughout the body and lack of typical clinical manifestations. In this case, a 25-year-old previously healthy woman was hospitalized with fulminant myocarditis and treated with veno-arterial extracorporeal membrane pulmonary oxygenation (VA-ECMO) support and intravenous acyclovir, high-dose methylprednisolone, and immunoglobulin.
View Article and Find Full Text PDFUpdates in Mucormycosis.
Infect Dis Clin North Am
December 2024
Transplant Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. Electronic address:
Mucormycosis is an aggressive and frequently lethal disease. Most patients with mucormycosis have poorly controlled diabetes mellitus and rhino-orbito-cerebral disease. Patients with hematologic malignancy and transplant recipients mostly present with rhino-orbito-cerebral or pulmonary disease.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!